Shree Ganesh Remedies Limited (SGRL.BO)
- Previous Close
756.45 - Open
762.05 - Bid 735.10 x --
- Ask 737.50 x --
- Day's Range
731.20 - 773.95 - 52 Week Range
617.20 - 950.00 - Volume
5,671 - Avg. Volume
6,681 - Market Cap (intraday)
9.478B - Beta (5Y Monthly) 0.41
- PE Ratio (TTM)
33.08 - EPS (TTM)
22.32 - Earnings Date May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 7, 2023
- 1y Target Est
--
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India. It provides anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including cyclopropanecarboxaldehyde, hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and various chemical applications. In addition, it is involved in customized chemistry development and manufacturing; assets and infrastructure; and customized process of pharmaceutical chemicals. The company also exports its products. It serves various industries, including pharmaceuticals, biotechnology, medical devices, and others. The company was incorporated in 1995 and is headquartered in Ankleshwar, India.
www.ganeshremedies.com139
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: SGRL.BO
View MorePerformance Overview: SGRL.BO
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGRL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGRL.BO
View MoreValuation Measures
Market Cap
9.71B
Enterprise Value
9.84B
Trailing P/E
33.94
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.96
Price/Book (mrq)
7.29
Enterprise Value/Revenue
8.07
Enterprise Value/EBITDA
20.19
Financial Highlights
Profitability and Income Statement
Profit Margin
23.34%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.22B
Net Income Avi to Common (ttm)
284.69M
Diluted EPS (ttm)
22.32
Balance Sheet and Cash Flow
Total Cash (mrq)
212.74M
Total Debt/Equity (mrq)
25.42%
Levered Free Cash Flow (ttm)
--